|
|
|
Insider
Information: |
Ajer Jeffrey Robert |
Relationship: |
Director |
City: |
Novato |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
100,920 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$5,960,592 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
100,920 |
|
|
Total
Value |
$5,960,592 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
3
|
Stock
price went up :
|
0
|
1
|
Stock
price went down : |
0
|
2
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
-61.3%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Biomarin Pharmaceutical Inc |
BMRN |
EVP, Chief Commercial ... |
2024-05-02 |
66,767 |
|
0 |
Premium* |
|
Nektar Therapeutics |
NKTR |
Director |
2023-09-18 |
34,153 |
2017-09-19 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
174 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 6 of 7
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
|
2024-03-15 |
4 |
D |
$83.87 |
$1,893,785 |
D/D |
(22,580) |
71,467 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
|
2018-03-21 |
4 |
AS |
$83.90 |
$366,475 |
D/D |
(4,368) |
60,153 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
|
2020-03-13 |
4 |
D |
$84.50 |
$645,918 |
D/D |
(7,644) |
63,886 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
|
2018-05-07 |
4 |
AS |
$85.96 |
$26,562 |
D/D |
(309) |
52,914 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
|
2016-05-03 |
4 |
AS |
$86.03 |
$35,701 |
D/D |
(415) |
63,072 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
|
2022-11-02 |
4 |
AS |
$86.12 |
$258,360 |
D/D |
(3,000) |
41,088 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
|
2024-03-05 |
4 |
AS |
$87.07 |
$348,280 |
D/D |
(4,000) |
94,047 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
|
2023-03-15 |
4 |
D |
$87.74 |
$348,416 |
D/D |
(3,971) |
85,996 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
|
2019-03-22 |
4 |
D |
$88.05 |
$316,804 |
D/D |
(3,598) |
51,131 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Commercial Officer |
|
2016-03-04 |
4 |
AS |
$88.42 |
$110,970 |
D/D |
(1,255) |
46,882 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
|
2017-03-29 |
4 |
AS |
$89.15 |
$346,794 |
D/D |
(3,890) |
51,532 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
|
2019-03-26 |
4 |
AS |
$89.18 |
$326,025 |
D/D |
(3,656) |
47,475 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Commercial Officer |
|
2016-03-03 |
4 |
D |
$89.57 |
$214,520 |
D/D |
(2,395) |
48,137 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
|
2017-06-07 |
4 |
AS |
$89.61 |
$89,968 |
D/D |
(1,004) |
47,944 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
|
2019-03-21 |
4 |
AS |
$89.62 |
$406,634 |
D/D |
(4,519) |
54,729 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
|
2016-06-03 |
4 |
D |
$90.00 |
$133,920 |
D/D |
(1,488) |
59,809 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
|
2023-08-16 |
4 |
AS |
$90.00 |
$450,000 |
D/D |
(5,000) |
60,804 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
|
2018-06-11 |
4 |
AS |
$90.31 |
$129,685 |
D/D |
(1,436) |
50,135 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
|
2017-03-07 |
4 |
AS |
$90.56 |
$452,800 |
D/D |
(5,000) |
46,510 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
|
2017-06-02 |
4 |
D |
$90.72 |
$134,991 |
D/D |
(1,488) |
48,948 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Commercial Of |
|
2014-12-03 |
4 |
S |
$91.01 |
$1,092,161 |
D/D |
(12,000) |
31,590 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
|
2017-05-15 |
4 |
D |
$91.50 |
$100,284 |
D/D |
(1,096) |
50,436 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
|
2018-11-14 |
4 |
AS |
$91.62 |
$829,359 |
D/D |
(9,000) |
49,135 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
|
2018-06-04 |
4 |
D |
$92.07 |
$130,187 |
D/D |
(1,414) |
51,571 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
|
2017-03-15 |
4 |
D |
$92.50 |
$304,140 |
D/D |
(3,288) |
43,222 |
0 |
- |
|
174 Records found
|
|
Page 6 of 7 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|